Robert S. Brown, President, Nx Stage Kidney Care at NxStage Medical, Inc. (NXTM), sold 44,400 shares at $19.00 ($844K) on 2015-11-03, disclosed to the SEC on 2015-11-04.
Scheduled sale ($844k) by President, Nx Stage Kidney Care under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NXTM | SELL | 2017-03-06 | $358K | — | Filing → |
| NXTM | SELL | 2017-02-15 | $138K | — | Filing → |
| NXTM | SELL | 2017-02-08 | $169K | — | Filing → |